Japan's Eisai to boost sales staff to focus on new Alzheimer's drug

TOKYO -- Japanese drugmaker Eisei will boost new graduate hires by 40% in the fiscal year starting in April as it plans to expand its sales force for its breakthrough Alzheimer's treatment, Nikkei has learned. Japanese regulators on Monday approved the drug, Lecanemab, to treat the brain-wasting…

#tokyo #eisei #biogen